These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 25501870)
41. Modern evaluation of liquisolid systems with varying amounts of liquid phase prepared using two different methods. Vraníková B; Gajdziok J; Vetchý D Biomed Res Int; 2015; 2015():608435. PubMed ID: 26075249 [TBL] [Abstract][Full Text] [Related]
42. Preparation and pharmaceutical evaluation of new tacrolimus-loaded solid self-emulsifying drug delivery system. Seo YG; Kim DW; Cho KH; Yousaf AM; Kim DS; Kim JH; Kim JO; Yong CS; Choi HG Arch Pharm Res; 2015 Feb; 38(2):223-8. PubMed ID: 25134927 [TBL] [Abstract][Full Text] [Related]
43. Low density porous carrier drug adsorption and release study by response surface methodology using different solvents. Sher P; Ingavle G; Ponrathnam S; Pawar AP Int J Pharm; 2007 Feb; 331(1):72-83. PubMed ID: 17030470 [TBL] [Abstract][Full Text] [Related]
45. Novel amorphous microporous silica spheres for controlled release applications. Verraedt E; Van den Mooter G; Martens JA J Pharm Sci; 2011 Oct; 100(10):4295-301. PubMed ID: 21567409 [TBL] [Abstract][Full Text] [Related]
46. Diffusion-Controlled Drug Release From the Mesoporous Magnesium Carbonate Upsalite(®). Zhang P; Zardán Gómez de la Torre T; Forsgren J; Bergström CAS; Strømme M J Pharm Sci; 2016 Feb; 105(2):657-663. PubMed ID: 26087956 [TBL] [Abstract][Full Text] [Related]
47. Increased dissolution rates of tranilast solid dispersions extruded with inorganic excipients. Maniruzzaman M; Ross SA; Islam MT; Scoutaris N; Nair A; Douroumis D Drug Dev Ind Pharm; 2017 Jun; 43(6):947-957. PubMed ID: 28122459 [TBL] [Abstract][Full Text] [Related]
48. Investigation of Dissolution Behavior HPMC/Eudragit Naiserová M; Kubová K; Vysloužil J; Pavloková S; Vetchý D; Urbanová M; Brus J; Vysloužil J; Kulich P AAPS PharmSciTech; 2018 Feb; 19(2):681-692. PubMed ID: 28971441 [TBL] [Abstract][Full Text] [Related]
49. Amorphization of Indomethacin by Co-Grinding with Neusilin US2: amorphization kinetics, physical stability and mechanism. Bahl D; Bogner RH Pharm Res; 2006 Oct; 23(10):2317-25. PubMed ID: 16927179 [TBL] [Abstract][Full Text] [Related]
50. Interaction of nicotine with magnesium aluminum silicate at different pHs: characterization of flocculate size, zeta potential and nicotine adsorption behavior. Suksri H; Pongjanyakul T Colloids Surf B Biointerfaces; 2008 Aug; 65(1):54-60. PubMed ID: 18395425 [TBL] [Abstract][Full Text] [Related]
51. The development of a butyrylcholinesterase porous pellet for innovative detection of cholinesterase inhibitors. Zeman J; Vetchý D; Franc A; Pavloková S; Pitschmann V; Matějovský L Eur J Pharm Sci; 2017 Nov; 109():548-555. PubMed ID: 28917965 [TBL] [Abstract][Full Text] [Related]
52. Comparison of the ability of various pharmaceutical silicates to amorphize and enhance dissolution of indomethacin upon co-grinding. Bahl D; Hudak J; Bogner RH Pharm Dev Technol; 2008; 13(3):255-69. PubMed ID: 18484494 [TBL] [Abstract][Full Text] [Related]
53. Development of solid self-nanoemulsifying granules (SSNEGs) of ondansetron hydrochloride with enhanced bioavailability potential. Beg S; Jena SS; Patra ChN; Rizwan M; Swain S; Sruti J; Rao ME; Singh B Colloids Surf B Biointerfaces; 2013 Jan; 101():414-23. PubMed ID: 23010049 [TBL] [Abstract][Full Text] [Related]
54. Effects of solid carriers on the crystalline properties, dissolution and bioavailability of flurbiprofen in solid self-nanoemulsifying drug delivery system (solid SNEDDS). Kang JH; Oh DH; Oh YK; Yong CS; Choi HG Eur J Pharm Biopharm; 2012 Feb; 80(2):289-97. PubMed ID: 22119666 [TBL] [Abstract][Full Text] [Related]
55. Melt Adsorption as a Manufacturing Method for Fine Particles of Wax Matrices without Any Agglomerates. Shiino K; Fujinami Y; Kimura SI; Iwao Y; Noguchi S; Itai S Chem Pharm Bull (Tokyo); 2017; 65(8):726-731. PubMed ID: 28768926 [TBL] [Abstract][Full Text] [Related]
57. Enhanced dissolution of celecoxib by supersaturating self-emulsifying drug delivery system (S-SEDDS) formulation. Song WH; Park JH; Yeom DW; Ahn BK; Lee KM; Lee SG; Woo HS; Choi YW Arch Pharm Res; 2013 Jan; 36(1):69-78. PubMed ID: 23325487 [TBL] [Abstract][Full Text] [Related]
58. Determination of flowable liquid retention potential of aluminometasilicate carrier for liquisolid systems preparation. Vraníková B; Gajdziok J; Vetchý D Pharm Dev Technol; 2015 Nov; 20(7):839-844. PubMed ID: 24927105 [TBL] [Abstract][Full Text] [Related]
59. Adsorption of meloxicam on porous calcium silicate: characterization and tablet formulation. Sharma S; Sher P; Badve S; Pawar AP AAPS PharmSciTech; 2005 Dec; 6(4):E618-25. PubMed ID: 16408863 [TBL] [Abstract][Full Text] [Related]
60. Bromocriptine tablet of self-microemulsifying system adsorbed onto porous carrier to stimulate lipoproteins secretion for brain cellular uptake. Thongrangsalit S; Phaechamud T; Lipipun V; Ritthidej GC Colloids Surf B Biointerfaces; 2015 Jul; 131():162-9. PubMed ID: 25988280 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]